Treatment relative effect with 95% CI; and degree of certainty (adaptated from GRADE). method
Treament | Trials | |||||
---|---|---|---|---|---|---|
clinical deterioration | clinical improvement | deaths | PCR-negative conversion | |||
anticoagulant | - | - | OBS 0.79 [0.53; 1.17], 9 studies, I2=91% inconclusive result | - | ||
colchicine | 0.11 [0.01; 1.08], 1 RCT, I2=0% inconclusive result | - | 0.31 [0.04; 2.15], 2 RCTs, I2=0% inconclusive result | - | ||
face mask | 0 | - | - | - | - | |
febuxostat | 0 | - | - | - | - | |
hydrogen-oxygen nebulizer | 0 | - | - | - | - | |
hyperbaric oxygen | 0 | - | - | - | - | |
nintedanib | 0 | - | - | - | - | |
pulmonary rehabilitation | 0 | - | - | - | - | |
thalidomide | 0 | - | - | - | - | |
vitamin C | 0 | - | - | - | - |